Briefs

AxCell Biosciences, a subsidiary of Cytogen Corporation, has announced that it is using IBM DB2 database technology to help its scientists chart the communication pathways within cells that enable proteins to interact and cause or prevent diseases.

AxCell researchers are using IBM DB2 Intelligent Miner to gain new insights into how proteins interact in complex cellular communication networks. Ultimately, this knowledge could help drug makers design more effective and less toxic drugs that can disrupt the communication systems of abnormal proteins without harming healthy cells.

For additional information, visit www.axcellbio.com.